Jocelyn Laporte Selected Research

Jocelyn Laporte Research Topics

Disease

80	Congenital Structural Myopathies (Centronuclear Myopathy) 05/2024 - 02/2002
39	Muscular Diseases (Myopathy) 03/2024 - 12/2003
7	Disease Progression 01/2022 - 01/2012
6	Inborn Genetic Diseases (Disease, Hereditary) 03/2024 - 08/2008
6	Muscle Weakness 01/2023 - 05/2011
6	Neuromuscular Diseases (Neuromuscular Disease) 01/2020 - 07/2006
5	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2011
5	Nemaline Myopathies (Nemaline Myopathy) 01/2020 - 12/2013
5	Neoplasms (Cancer) 01/2020 - 02/2008
4	Myotonic Dystrophy (Dystrophia Myotonica) 11/2014 - 09/2002
3	Muscle Hypotonia (Hypotonia) 01/2021 - 06/2013
3	Malignant Hyperthermia 01/2021 - 10/2012
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2017 - 08/2008
3	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 06/2013 - 09/2002
2	Stormorken Syndrome 03/2024 - 12/2018
2	Muscular Atrophy (Muscle Atrophy) 10/2023 - 01/2023
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 01/2018
2	Central Core Myopathy (Central Core Disease) 01/2021 - 11/2017
2	Myofibrillar Myopathy 01/2020 - 06/2015
2	Atrophy 08/2018 - 10/2017
2	Hypospadias 01/2009 - 12/2006
2	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 08/2008 - 12/2007
1	Seizures (Absence Seizure) 01/2024
1	Epilepsy (Aura) 01/2024
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Brain Diseases (Brain Disorder) 01/2020
1	Glycogen Storage Disease (Glycogenosis) 01/2020
1	Distal Myopathies (Distal Muscular Dystrophy) 01/2020
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2019
1	Paralysis (Palsy) 11/2018
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Pathologic Processes 01/2018
1	Proteostasis Deficiencies 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Dermatomyositis (Dermatopolymyositis) 10/2017
1	Inflammation (Inflammations) 10/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2017
1	Experimental Nervous System Autoimmune Disease 10/2017

Drug/Important Bio-Agent (IBA)

37	myotubularinIBA 01/2023 - 02/2002
30	Dynamin IIIBA 01/2023 - 11/2005
21	amphiphysinIBA 05/2024 - 09/2007
20	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2005
13	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2023 - 08/2002
10	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2022 - 02/2004
8	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 10/2021 - 10/2012
7	phosphatidylinositol 3-phosphateIBA 01/2023 - 08/2002
6	Phosphoinositide PhosphatasesIBA 10/2021 - 09/2007
5	LipidsIBA 10/2023 - 02/2004
5	Antisense OligonucleotidesIBA 01/2022 - 01/2017
5	Dynamins (Dynamin)IBA 01/2022 - 01/2012
5	GTP Phosphohydrolases (GTPases)IBA 01/2020 - 12/2007
4	ConnectinIBA 03/2024 - 10/2013
4	Tamoxifen FDA LinkGeneric 01/2023 - 11/2018
4	Protein Isoforms (Isoforms)IBA 11/2022 - 02/2011
3	Protein Kinases (Protein Kinase)IBA 03/2024 - 01/2018
3	Phosphotransferases (Kinase)IBA 02/2024 - 01/2017
3	EnzymesIBA 11/2023 - 08/2008
3	CalciumIBA 10/2021 - 02/2013
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2011
3	Small Interfering RNA (siRNA)IBA 01/2018 - 02/2008
3	nebulinIBA 10/2015 - 04/2014
3	Nonsense Codon (Nonsense Mutation)IBA 09/2015 - 12/2006
3	DesminIBA 06/2015 - 01/2011
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 08/2013
2	UbiquitinIBA 01/2023 - 08/2013
2	Oxidoreductases (Dehydrogenase)IBA 01/2019 - 11/2016
2	CalsequestrinIBA 12/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 01/2009
2	Testosterone (Sustanon)FDA Link 01/2009 - 02/2008
2	P-2 (P 2)IBA 08/2008 - 04/2004
2	phosphatidylinositol 3,5-diphosphateIBA 11/2006 - 02/2004
1	Serine (L-Serine)FDA Link 03/2024
1	Muscle Proteins (Muscle Protein)IBA 03/2024
1	Pentylenetetrazole (Metrazol)IBA 01/2024
1	Cullin Proteins (Cullins)IBA 01/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2022
1	IntegrinsIBA 10/2022
1	Myosin-Light-Chain KinaseIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	ProteomeIBA 01/2021
1	Myosins (Myosin)IBA 12/2020
1	MyostatinIBA 06/2020
1	Biomarkers (Surrogate Marker)IBA 06/2020
1	GlycogenIBA 01/2020
1	FilaminsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Codon (Codons)IBA 10/2019
1	BuffersIBA 12/2018
1	CollagenIBA 08/2018
1	Cytoskeletal ProteinsIBA 01/2018
1	Cysteine (L-Cysteine)FDA Link 10/2017
1	Interferon Type IIBA 10/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017

Therapy/Procedure

13	Therapeutics 03/2024 - 06/2011
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Intramuscular Injections 01/2018